Two vision researchers at the University of Wisconsin-Madison are involved in groundbreaking research aimed at curing blindness through human eye transplantation. To date, there has never been a successful whole human eye transplant for the restoration of vision. However, research teams across the country, including at the University of Wisconsin—Madison, are hopeful these efforts will pave the way for this procedure.
Research News
Taking Steps to Restore Vision: Launching a Stem Cell Clinical Trial for Retinitis Pigmentosa
The FDA has approved a groundbreaking stem cell clinical trial for retinitis pigmentosa. The trial is the next step in the work spearheaded by world-renowned vision researcher David Gamm, MD, PhD.
Equal Vision: Employing Artificial Intelligence to Reduce Disparities in the Diagnosis and Treatment of Vision Loss
Roomasa Channa, MD is utilizing artificial intelligence technology to improve screening and detection of diabetic eye disease, the leading cause of vision loss among working aged adults in the U.S.
UW—Madison Scientists Seek to Revolutionize Eye Care with Adaptive Optics Technology
Vision scientists at the University of Wisconsin—Madison are pioneering a revolutionary approach to eye care by adapting a cutting-edge imaging technique from astronomy for use in ophthalmology.
4-Year-Old Entlebucher Lost Both Eyes to Glaucoma, But… Finn Still Loves to Fetch
This article was originally published by the School of Veterinary Medicine. Photos of Finn courtesy of the Caho family. Watching Finn and Luka, two beautiful and energetic Entlebucher Mountain Dogs, play fetch in their backyard …
Nanoparticles subdue antibiotic-resistant bacteria’s defences while enhancing innate immunity
A method for overcoming antibiotic resistance uses multimodal nanoparticles that target bacterial defence mechanisms while enhancing the innate immune response. The rise in antibiotic resistance is considered a slow-moving medical catastrophe, as these revolutionary drugs that have kept us relatively safe from bacterial infection for decades are losing their efficacy. In part due to their co-evolution, bacterial pathogens have developed mechanisms to resist almost every antibiotic on the market and we are in desperate need for new, innovative approaches. Writing in Nature Nanotechnology, Zhu et al. present a nanoparticle-based possibility, in which they target bacterial defence mechanisms while simultaneously enhancing the ability of the host immune cells to fight infection.
Introducing the 2024 Kambara Symposium Keynote Speaker: Budd Tucker, PhD
A highly accomplished vision scientist and expert in retinal disease will be the keynote speaker at the 2023 George Kambara, MD Vision Science Symposium on Friday, April 14, 2024.
New Vision Research Utilizes “Cell” Sequencing to Shed Light on Childhood Glaucoma
Stuart Tompson, PhD and colleagues at the University of Wisconsin—Madison are exploring a novel cell profiling approach to understand Primary Congenital Glaucoma (PCG). PCG is a severe pediatric eye disease affecting 1 in 10,000 infants …
Testing Senses and Motor Skills in Midlife May Help Predict Later Cognitive Impairment
When researchers test motor skills, hearing, vision, and smell in people in their midlife, they are better able to identify those who may develop cognitive decline or impairment 10 years later, according to a new …